← FDA Drug Approvals (Drugs@FDA)

TREPROSTINIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC GLOBAL · Approved 2021-02-11

Drug application

FDA Application #

ANDA211574

Application type

Abbreviated New Drug Application (Generic)

Brand name

TREPROSTINIL

Generic name

TREPROSTINIL

Active ingredients

TREPROSTINIL

Dosage form

INJECTABLE

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ALEMBIC GLOBAL

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2021-02-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown